[go: up one dir, main page]

CO4230230A1 - Nuevas sulfonilaminopirimidinas - Google Patents

Nuevas sulfonilaminopirimidinas

Info

Publication number
CO4230230A1
CO4230230A1 CO94027814A CO94027814A CO4230230A1 CO 4230230 A1 CO4230230 A1 CO 4230230A1 CO 94027814 A CO94027814 A CO 94027814A CO 94027814 A CO94027814 A CO 94027814A CO 4230230 A1 CO4230230 A1 CO 4230230A1
Authority
CO
Colombia
Prior art keywords
rent
alcoxyl
alkyl
alkoxy
lower alkyl
Prior art date
Application number
CO94027814A
Other languages
English (en)
Inventor
Breu Volker
Burri Kaspar
Jean Marie Cassal
Martine Clozel
Georges Hirth
Bernd-Michae Loffler
Marcel Muller
Werner Neidhart
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4230230A1 publication Critical patent/CO4230230A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REIVINDICACION NUMERO CONPUESTOS DE LA FORMULA FIGURA 1. EN DONDE R1-R3 SIGNIFICAN INDEPENDIENTEMENTE HIDROGENO, AL- QUILO INFERIOR, ALCOXILO INFERIOR, ALQUILTIO INFE- RIOR, ALQUENILO INFERIOR, HALOGENO, TRIFLUOROMETI- LO, HIDROXI-ALCOXILO INFERIOR, HALO-ALCOXILO INFE- RIOR, CICLOALQUILO INFERIOR, HIDROXI-ALCANOILAMINO INFERIOR-ALCOXILO INFERIOR, ALCANOILAMINO-ALQUILO INFERIOR, CARBOXI-ALCOXILO INFERIOR, CARBOXI- ALQUILO INFERIOR, ALCOXICARBONILO INFERIOR-ALQUILO INFERIOR, ALCOXICARBONIL-ALCOXILO INFERIOR, ALCA- NOILOXI-ALCOXILO INFERIOR, ALCANOILOXI-ALQUILO IN- FERIOR, ALCOXICARBONILO, CARBOXILO, AMINO, MONO- O DI(ALQUILO INFERIOR) AMINO O UN RADICAL (Rc, Rd)N- C(O) (CH2)(SUB 0-4)O- o (Rc,Rd)N-C(O)(CH2)(SUB O- 4); R2 Y R3 JUNTOS SIGNIFICAN BUTADIENILO, METILENDIO- XILO, ETILENDIOXILO O ISOPROPILIDENDIOXILO; R4 SIGNIFICA HIDROGENO, ALQUILO INFERIOR, CICLO- ALQUILO INFERIOR, TRIFLUOROMETILO, ALCOXILO INFE- RIOR, ALQUINILOXILO INFERIOR, ALQUILTIO INFERIOR, ALQUILTIO INFERIOR ALQUILO INFERIOR, ALQUILTIO IN- FERIOR-ALCOXILO INFERIOR, HIDROXI-ALCOXILO INFE- RIOR, DIHIDROXI-ALCOXILO INFERIOR, ALCOXILO INFE- RIOR-ALQUILO INFERIOR, HIDROXI-ALCOXILO INFERIOR- ALQUILO INFERIOR, **** PENDIENTE HOJA NUMERO DOS EXTRACTO *****
CO94027814A 1993-06-28 1994-06-27 Nuevas sulfonilaminopirimidinas CO4230230A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH192493 1993-06-28

Publications (1)

Publication Number Publication Date
CO4230230A1 true CO4230230A1 (es) 1995-10-19

Family

ID=4221780

Family Applications (1)

Application Number Title Priority Date Filing Date
CO94027814A CO4230230A1 (es) 1993-06-28 1994-06-27 Nuevas sulfonilaminopirimidinas

Country Status (41)

Country Link
US (1) US5541186A (es)
EP (1) EP0633259B1 (es)
JP (1) JP2545200B2 (es)
KR (1) KR100338905B1 (es)
CN (1) CN1050839C (es)
AT (1) ATE175669T1 (es)
AU (1) AU678467B2 (es)
BG (1) BG61691B1 (es)
BR (2) BR9402558A (es)
CA (1) CA2125730C (es)
CO (1) CO4230230A1 (es)
CZ (1) CZ287184B6 (es)
DE (1) DE59407626D1 (es)
DK (1) DK0633259T3 (es)
EC (1) ECSP941111A (es)
ES (1) ES2127850T3 (es)
FI (1) FI112944B (es)
GR (1) GR3029874T3 (es)
HR (1) HRP940370B1 (es)
HU (2) HUT67636A (es)
IL (1) IL110089A (es)
IS (1) IS4185A (es)
LT (1) LT3723B (es)
LV (1) LV11175B (es)
MY (1) MY110871A (es)
NO (1) NO306403B1 (es)
NZ (1) NZ260842A (es)
PE (1) PE56794A1 (es)
PH (1) PH30688A (es)
PL (2) PL177031B1 (es)
RO (1) RO114325B1 (es)
RU (1) RU2142457C1 (es)
SG (1) SG43888A1 (es)
SI (1) SI0633259T1 (es)
SK (1) SK280736B6 (es)
SV (1) SV1994000028A (es)
TW (1) TW394761B (es)
UA (1) UA40578C2 (es)
UY (1) UY23797A1 (es)
YU (1) YU40794A (es)
ZA (1) ZA944434B (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
EE9700209A (et) 1994-11-16 1998-04-15 Synaptic Pharmaceutical Corporation Dihüdropürimidiinid ja nende kasutamine
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
RU2151767C1 (ru) * 1994-12-20 2000-06-27 Ф.Хоффманн-Ля Рош Аг Сульфонамиды и фармацевтическая композиция
TW313568B (es) * 1994-12-20 1997-08-21 Hoffmann La Roche
CN1171785A (zh) 1994-12-28 1998-01-28 兴和株式会社 嘧啶衍生物
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5573762A (en) * 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
US5739333A (en) * 1995-05-16 1998-04-14 Tanabe Seiyaku Co., Ltd. Sulfonamide derivative and process for preparing the same
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
ATE254607T1 (de) * 1995-09-06 2003-12-15 Kowa Co Pyrimidinderivate
JPH09124620A (ja) * 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
CZ260596A3 (en) * 1995-10-12 1997-12-17 Hoffmann La Roche Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
CN1102580C (zh) * 1995-12-20 2003-03-05 山之内制药株式会社 芳基乙烯基磺酰胺衍生物及其医药组合物
WO1997029747A1 (en) 1996-02-20 1997-08-21 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
WO1998011913A1 (en) * 1996-09-16 1998-03-26 Dalhousie University Use of igf-i for the treatment of polycystic kidney disease and related indications
AU6187898A (en) * 1997-01-30 1998-08-25 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
CA2315614C (en) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles
AU2001265871A1 (en) * 2000-04-25 2001-11-07 Actelion Pharmaceuticals Ltd Substituted sulfonylaminopyrimidines
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
MY140724A (en) 2000-07-21 2010-01-15 Actelion Pharmaceuticals Ltd Novel arylethene-sulfonamides
US6670362B2 (en) 2000-09-20 2003-12-30 Pfizer Inc. Pyridazine endothelin antagonists
JP2004509874A (ja) 2000-09-25 2004-04-02 アクテリオン　ファマシューティカルズ　リミテッド 新規なアリールアルカン−スルフォンアミド類
WO2002032882A1 (en) * 2000-10-17 2002-04-25 Ihara Chemical Industry Co., Ltd. Process for producing substituted aniline compound
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
KR100374326B1 (ko) * 2000-11-29 2003-03-03 한국과학기술연구원 6-히드록시-1, 3-디옥신-4-온 고리를 가진인간면역결핍바이러스 프로테아제 억제 화합물 및 그의제조방법
AU2002227984B8 (en) 2000-12-18 2007-01-04 Actelion Pharmaceuticals Ltd. Novel sulfamides and their use as endothelin receptor antagonists
WO2002083650A1 (en) * 2001-04-11 2002-10-24 Actelion Pharmaceuticals Ltd Novel sulfonylamino-pyrimidines
AU2011218661B2 (en) * 2002-05-24 2012-07-05 Millennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof
CA2485681C (en) 2002-05-24 2012-10-16 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US7227035B2 (en) * 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7741519B2 (en) * 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
ATE363470T1 (de) 2002-11-18 2007-06-15 Chemocentryx Inc Arylsulfonamide
EP1569914B1 (en) 2002-12-02 2009-02-18 Actelion Pharmaceuticals Ltd. Pyrimidine-sulfamides and their use as endothelian receptor antagonist
DE102004027119A1 (de) 2003-06-06 2004-12-30 Schott Ag UV-Strahlung absorbierendes Glas mit geringer Absorption im sichtbaren Bereich, ein Verfahren zu seiner Herstellung sowie dessen Verwendung
ES2548022T3 (es) * 2004-03-05 2015-10-13 F. Hoffmann-La Roche Ag Diaminopirimidinas como antagonistas de P2X3 y P2X2/3
AU2005244745B2 (en) * 2004-04-13 2012-05-03 Synta Pharmaceuticals Corp. Disalt inhibitors of IL-12 production
JP4809339B2 (ja) 2004-06-28 2011-11-09 エフ．ホフマン−ラ ロシュ アーゲー ピリミジン誘導体
KR100847203B1 (ko) * 2004-06-28 2008-07-17 에프. 호프만-라 로슈 아게 피리미딘 유도체
TW200628467A (en) 2004-11-11 2006-08-16 Actelion Pharmaceuticals Ltd Novel sulfamides
BRPI0615613A2 (pt) * 2005-09-01 2009-05-19 Hoffmann La Roche diaminopirimidinas como moduladores de p2x3 e p3x2/3
EP1924564B1 (en) * 2005-09-01 2016-11-09 F.Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
ES2562056T3 (es) 2005-09-01 2016-03-02 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores P2X3 y P2X2/3
JP2009530280A (ja) * 2006-03-13 2009-08-27 エンサイシブ・ファーマシューティカルズ・インコーポレイテッド シタクスセンタンナトリウムの配合物
CN101404981A (zh) * 2006-03-13 2009-04-08 恩希赛弗制药公司 治疗舒张性心力衰竭的方法和组合物
US20080026061A1 (en) * 2006-06-22 2008-01-31 Reichwein John F Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
AR062501A1 (es) 2006-08-29 2008-11-12 Actelion Pharmaceuticals Ltd Composiciones terapeuticas
ES2621018T3 (es) 2007-02-19 2017-06-30 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
MX2010001837A (es) 2007-08-17 2010-03-10 Actelion Pharmaceuticals Ltd Derivados de 4-pirimidinasulfamida.
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
WO2012142581A1 (en) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acety glucosamine nanofibers
RU2604060C1 (ru) * 2015-10-06 2016-12-10 федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) Способ получения 2,5-дизамещенных 6-гидроксипиримидин-4(3н)-онов
PT3433234T (pt) 2016-03-22 2021-12-22 Merck Sharp & Dohme Moduladores alostéricos de recetores de acetilcolina nicotínica
RU2643356C2 (ru) * 2016-06-22 2018-02-01 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Новое n-арилсульфамидное производное о-бензоиламинобензойной кислоты, обладающее анксиолитической, актопротекторной и антидепрессивной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210526B1 (de) 1985-07-24 1989-05-24 Siemens Aktiengesellschaft Kernreaktorbrennelement
TW270116B (es) * 1991-04-25 1996-02-11 Hoffmann La Roche
RU2086544C1 (ru) 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW287160B (es) * 1992-12-10 1996-10-01 Hoffmann La Roche

Also Published As

Publication number Publication date
IS4185A (is) 1994-12-29
LV11175B (en) 1996-06-20
MY110871A (en) 1999-05-31
JP2545200B2 (ja) 1996-10-16
TW394761B (en) 2000-06-21
BR1100089A (pt) 2000-03-14
AU678467B2 (en) 1997-05-29
CN1050839C (zh) 2000-03-29
SG43888A1 (en) 1997-11-14
RU94022258A (ru) 1996-04-20
HRP940370A2 (en) 1996-12-31
RU2142457C1 (ru) 1999-12-10
PL304007A1 (en) 1995-01-09
SK77994A3 (en) 1995-03-08
HRP940370B1 (en) 1999-12-31
NO942428D0 (no) 1994-06-27
PL177031B1 (pl) 1999-09-30
US5541186A (en) 1996-07-30
LT3723B (en) 1996-02-26
RO114325B1 (ro) 1999-03-30
ECSP941111A (es) 1994-11-16
PL175771B1 (pl) 1999-02-26
GR3029874T3 (en) 1999-07-30
UA40578C2 (uk) 2001-08-15
LV11175A (lv) 1996-04-20
CA2125730C (en) 2005-10-18
HU9401907D0 (en) 1994-09-28
HUT67636A (en) 1995-04-28
SK280736B6 (sk) 2000-07-11
EP0633259A1 (de) 1995-01-11
FI943084A7 (fi) 1994-12-29
BG98880A (bg) 1995-05-31
CN1106007A (zh) 1995-08-02
FI943084A0 (fi) 1994-06-27
DE59407626D1 (de) 1999-02-25
KR950000676A (ko) 1995-01-03
EP0633259B1 (de) 1999-01-13
CZ157394A3 (en) 1995-01-18
NZ260842A (en) 1996-05-28
SI0633259T1 (en) 1999-06-30
JPH0717972A (ja) 1995-01-20
SV1994000028A (es) 1995-04-19
PH30688A (en) 1997-09-16
CZ287184B6 (en) 2000-10-11
BG61691B1 (bg) 1998-03-31
NO942428L (no) 1994-12-29
HU211533A9 (en) 1995-12-28
UY23797A1 (es) 1994-12-16
ATE175669T1 (de) 1999-01-15
NO306403B1 (no) 1999-11-01
ZA944434B (en) 1995-01-03
KR100338905B1 (ko) 2002-11-13
IL110089A0 (en) 1994-10-07
YU40794A (sh) 1997-07-31
PE56794A1 (es) 1995-02-07
DK0633259T3 (da) 1999-09-06
LTIP1979A (en) 1995-01-31
FI112944B (fi) 2004-02-13
CA2125730A1 (en) 1994-12-29
BR9402558A (pt) 1995-03-28
AU6594894A (en) 1995-01-05
ES2127850T3 (es) 1999-05-01
IL110089A (en) 2000-08-31

Similar Documents

Publication Publication Date Title
CO4230230A1 (es) Nuevas sulfonilaminopirimidinas
DE3669443D1 (de) Fluidfilter mit gefaltetem filtermedium.
ITMI921535A0 (it) Procedimento per la deidrogenazione di paraffine leggere in un reattore a letto fluido
DE3751201D1 (de) Mono- und disubstituierte Phthalocyanine.
ZA861047B (en) Reducing mode circulating fluid bed combustion
FI843522L (fi) 1-heteroaryl-4/(2,5-pyrrolidindion-1-yl) alkyl/piperazinderivat.
DE69106022D1 (de) Verlängerung der Einsatzzeit eines Siedewasserreaktors in Betrieb.
ATE143404T1 (de) Tinte, tintenstrahldruck-aufzeichnungsverfahren und verwendung dieser tinte
DE69226250D1 (de) Dispersionen von mikroausgefällten Methinoxonolfilterfarbstoffen
DE69121785D1 (de) Elektrophotographische Aufzeichnungselemente, die eine Kombination von Titanylphthalocyanin-Pigmenten enthalten
DE58904761D1 (de) Chirale derivate des 1,2 -difluorbenzols.
FI943817A7 (fi) Bisyklo/2.2.2/oktaanijohdannaisia kolestokystokiniinin inhibiittoreina
DE69204290D1 (de) Verwendung von 1,2,2,3,3-pentafluorpropan.
DE68913397D1 (de) Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen.
DE59107353D1 (de) Kationische 1,3,4-Thiadiazolfarbstoffe
GR3006440T3 (es)
GB8713417D0 (en) Fluid light controlling medium
DE59201470D1 (de) Verwendung von alkylglykosiden als textilhilfsmittel.
ATE72967T1 (de) Verwendung von 2,6-dinitro-anilinderivaten in haarfaerbemitteln und neue 2,6-dinitroanilinderivate.
FI942886A0 (fi) Keittolaite
FR2691957B1 (fr) Table de marge de machines à imprimer.
FI855132A0 (fi) 2,3-diamino-2,3 -didesoxyhexosderivat, foerfarande foer deras framstaellning och deras anvaendning.
IT8220860V0 (it) Assorbitore integrale di calore d'irradiazione a circolazione di fluido per pentola a fornello a fiamma.
GB2077751A (en) Disperse methine dyes from heterocyclic acetonitriles
KR910018544U (ko) 미니보일러용 분사식 석유버어너